Brenda Thompson: Daily

A major national advocacy firm is doubling down on California, pairing two of Sacramento’s heaviest hitters. It’s a move that signals a larger shift in how influence is wielded, from coast to coast.

As CRN UK honors HYCU’s Wendy Inwood, we explore her pivotal role in building a partner-first ecosystem and what it signals for women in tech leadership.

With record fundraising and a massive $170 billion in dry powder, Ares is not just navigating a slow market—it's preparing to reshape it. Here's the strategy.

Australia is a top choice for Hong Kong students, but new visa rules and complex applications require a strategic approach. Here's how to navigate the path.

Entropy Inc. launches a first-of-its-kind low-carbon power plant in Alberta, but warns that bureaucratic delays in green incentives threaten Canada's climate goals.

Kioxia's new CM10 SSDs bring PCIe 6.0 speed and liquid cooling to data centers, directly tackling the immense data demands of tomorrow's AI models.

A key solar supplier, Daqo New Energy, is tackling the huge carbon footprint of polysilicon. Its new ESG goals could redefine the entire green energy supply chain.

With a history of beating expectations and a new acquisition in tow, all eyes are on Calian's Q3 results to see if its mission-critical strategy can sustain momentum.

At AMB 2026, Dormer Pramet unveils advanced cutting tools. This isn't just new metal; it's a strategic push for productivity, reliability, and sustainability.

As Agilent prepares its Q3 report, the numbers are more than finance; they are a key signal for the future of diagnostics and life sciences innovation.

CliniComp's new VA Salem ICU contract highlights a different path for VA tech: one built on trust, reliability, and AI-enabled clinical support.

Singapore's EUDA Health is moving from wellness products to pioneering 'off-the-shelf' cell therapies for cancer, a risky but potentially transformative leap.

Beyond 20M sales, Chery Auto's true power lies in its strategy. A deep dive into the financial muscle and localized doctrine driving its LEPAS NEV brand.

With its $2.2B acquisition of Forte, argenx adds a first-in-class antibody, FB102, expanding its Vision 2030 strategy to redefine autoimmune care.

Orlando World Center Marriott's 'Twelve Nights of Wonder' reveals a new strategy: creating a self-contained holiday ecosystem to captivate families.

New AI assistants are revolutionizing chip design, creating the high-capacity, low-power memory needed to unlock the true potential of AI on our everyday devices.

A struggling medical AI firm plans a merger with a crypto miner. Is this a desperate act or a brilliant new model for funding deep tech innovation in 2026?

A new AI 'orchestration layer' is earning awards and changing how utilities communicate. We explore how ConveyIQ is moving beyond compliance to rebuild trust.

JARS Digital's CairnMetrics offers SMBs an AI analyst to unify data and deliver enterprise-level insights, aiming to end decision-making by 'gut feel'.

A new filmmaker-led studio, vertTV, bets on star power and cinematic quality for mobile micro-series. But can it succeed where others, like Quibi, failed?